A pooled case-only analysis of obesity and breast cancer subtype among Black women in the southeastern United States

Cancer Causes Control. 2022 Apr;33(4):515-524. doi: 10.1007/s10552-021-01545-8. Epub 2022 Jan 28.

Abstract

Purpose: To evaluate the association between obesity and the relative prevalence of tumor subtypes among Black women with breast cancer (BC).

Methods: We conducted a pooled case-only analysis of 1,793 Black women with invasive BC recruited through three existing studies in the southeastern US. Multivariable case-only polytomous logistic regression models were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for the association between obesity, measured by pre-diagnostic body mass index (BMI), and human epidermal growth factor receptor 2 + (HER2 +) and triple negative BC (TNBC) subtype relative to hormone receptor (HR) + /HER2- status (referent).

Results: Among 359 premenopausal women, 55.4% of cases were HR + /HER2 -, 20.1% were HER2 + , and 24.5% were TNBC; corresponding percentages among 1,434 postmenopausal women were 59.3%, 17.0%, and 23.6%. Approximately, 50-60% of both pre- and postmenopausal women were obese (BMI > 30 kg/m2), regardless of BC subtype. We did not observe a significant association between obesity and BC subtype. Among postmenopausal women, class I obesity (BMI 35 + kg/m2) was not associated with the development of HER2 + BC (OR 0.69; 95% CI 0.42-1.14) or TNBC (OR 0.93; 95% CI 0.60-1.45) relative to HR + /HER2- tumors. Corresponding estimates among premenopausal women were 1.03 (95% CI 0.43-2.48) and 1.13 (95% CI 0.48-2.64).

Conclusion: In this large study of Black women with BC, there was no evidence of heterogeneity of BMI by BC subtype.

Keywords: Black Women; Breast cancer; Breast cancer subtypes; Obesity; Postmenopausal; Premenopausal.

MeSH terms

  • Black or African American* / statistics & numerical data
  • Body Mass Index
  • Breast Neoplasms* / epidemiology
  • Breast Neoplasms* / metabolism
  • Female
  • Humans
  • Obesity*
  • Premenopause
  • Receptor, ErbB-2 / metabolism
  • Receptors, Progesterone / metabolism
  • Risk Factors
  • Southeastern United States / epidemiology
  • Triple Negative Breast Neoplasms* / epidemiology

Substances

  • Receptors, Progesterone
  • ERBB2 protein, human
  • Receptor, ErbB-2